Up to 15 companies will be selected from the applicant pool to take part in each cohort anchored around key activities in the state. The Fall 2026 Cohort will focus on biotech and health tech and will coincide with Arizona Bioscience Week, kicking off on October 5, 2026. Applications close August 7, 2026.Continue reading
Author Archive: AZBio
Feedback Sought on Proposals to Reform Pharmaceutical Pricing, Bolster Innovation
On June 16, 2026, Senate Finance Committee Ranking Member Ron Wyden (D-OR) released a request for information on a host of proposals aimed at lowering the cost of prescription drugs, as a part of Senate Democrats’ work to make health care affordable for all Americans. Text of the Request for Information (PDF) Members of the public are encouraged to weigh in with feedback by August 17, 2026.
The request for information focuses on three policy objectives:
- Lowering the price manufacturers charge for prescription drugs
- Lowering out-of-pocket costs for patients
- Fostering biopharmaceutical innovation in areas of unmet need, bolstering domestic clinical trials, and recruiting and maintaining scientific talent
TGen scientists identify nanobody that can be engineered to clear Alzheimer’s plaques
Fusion antibody was comparable to aducanumab treatment in clearing amyloid plaques in mice
How do different dementia pathologies interact in the mouse brain?
TGen-led study clarifies interactions between amyloid, tau, alpha-synuclein proteins
Partnership Creates a Bridge Between Arizona and Taiwan Life Science Communities
The Arizona Bioindustry Association, Inc. (AZBio) and Bio Taiwan execute a Memorandum of Understanding focused on fostering collaborations between organizations in the Arizona and Taiwan life science sectors at the 2026 BIO International Convention in San Diego.
GT Medical Technologies Completes Oversubscribed $100 Million Series E Equity Financing to Advance Commercial Treatment for Patients with Operable Brain Tumors
Financing round led by new investor Viking Global Investors with participation from key existing investorsContinue reading
Picard Medical / SynCardia Advances Emperor Total Artificial Heart Program with Successful Next-Generation Preclinical Implant Studies
— Independent dual motor ventricular design demonstrates stable full circulatory support across all study procedures —
— Advancing second-generation Emperor TAH development toward a fully implantable system —
Continue reading
NIH SBIR and STTR Parent Notices of Funding Opportunity (NOFOs) have officially been released
These programs provide non-dilutive funding to help small businesses advance innovative technologies and bring promising discoveries closer to commercialization. Whether you’re developing a new therapeutic, diagnostic, medical device, digital health solution, or research tool, NIH funding can help accelerate your path forward.Continue reading
Banner Health report shows Arizona research driving national medical innovation
Milestones in Research details 1,300 clinical and translational research studies, FDA-approved heart device, landmark Alzheimer’s prevention work